Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070328 · ClinicalTrials.gov registry record
Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up
A clinical trial of Cancer, sponsored by Center for Biomedical Research.
- Recruiting
- Registry status
- 300
- Enrollment target
- 3
- Study locations
NCT02070328: Recruiting study of Cancer, sponsored by Center for Biomedical Research.
NCT02070328 is a study of Cancer that is actively recruiting participants, run by Center for Biomedical Research. The registered enrollment target is 300 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02070328, a study of Cancer, is actively recruiting participants, sponsored by Center for Biomedical Research.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
Proton therapy is a limited medical resource that is more expensive than conventional x-ray therapy. To correctly measure the success of proton therapy in treating different conditions, it is important to check a patient's health status after their treatment is finished. Checking on the progress of patients over many years (called long-term follow-up) is needed because the long-term effects of proton therapy are not well known.
Primary Outcome
Maintaining regular, lifetime contact with subjects in order to obtain current identification , contact information, and self/parent-reported health status in order to obtain a better understanding of overall treatment strategies and patient benefits of treatment.
Conditions Studied
Interventions
- OTHER Registry
Study Locations (3)
Florida
- Ackerman Cancer Center - Jacksonville
Tennessee
- Provision CARES Proton Therapy Nashville - Franklin
Texas
- Texas Center for Proton Therapy - Irving
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-12 |
| Est. Completion | 2050-01 |
What NCT02070328 shows while recruiting
NCT02070328 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Registry is the first listed.
NCT02070328 reports a single indexed study location in Florida, Tennessee, Texas.
Frequently Asked Questions
What is clinical trial NCT02070328 about?
NCT02070328 is a clinical study titled "Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up". Proton therapy is a limited medical resource that is more expensive than conventional x-ray therapy. To correctly measure the success of proton therapy in treating different conditions, it is important to check a patient's health status after their treatment is finished. Checking on the progress of ...
What is the current status of trial NCT02070328?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2013-12. Estimated completion is 2050-01.
What conditions does trial NCT02070328 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT02070328?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT02070328?
This trial is sponsored by Center for Biomedical Research, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02070328 being conducted?
This trial has 3 study locations across Florida, Tennessee, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02070328's enrollment target sits among peer trials
300 179th of 615 higher than 428 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia